<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T20:39:33Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/189190" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/189190</identifier><datestamp>2025-12-05T04:21:30Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478809</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis</dc:title>
   <dc:creator>Darbà, Josep</dc:creator>
   <dc:creator>Marsà, Alícia</dc:creator>
   <dc:subject>Policitèmia</dc:subject>
   <dc:subject>Política sanitària</dc:subject>
   <dc:subject>Cost de l'assistència sanitària</dc:subject>
   <dc:subject>Polycythemia</dc:subject>
   <dc:subject>Medical policy</dc:subject>
   <dc:subject>Cost of medical care</dc:subject>
   <dc:description>Polycythemia vera (PV) is one of the most common chronic myeloproliferative neoplasms, yet, little data is available on the epidemiology of PV in Spain and the costs of its management. This study aimed to evaluate the hospital incidence and mortality rate of PV in Spain, and to estimate hospital medical costs.</dc:description>
   <dc:date>2022-09-20T11:49:00Z</dc:date>
   <dc:date>2023-10-31T06:10:25Z</dc:date>
   <dc:date>2022-10</dc:date>
   <dc:date>2022-09-20T11:49:00Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:identifier>1473-7167</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/189190</dc:identifier>
   <dc:identifier>717904</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2029413</dc:relation>
   <dc:relation>Expert Review of Pharmacoeconomics &amp; Outcomes Research, 2022, vol. 22, num. 6, p. 965-970</dc:relation>
   <dc:relation>https://doi.org/10.1080/14737167.2022.2029413</dc:relation>
   <dc:rights>(c) Informa Healthcare, 2022</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>6 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Informa Healthcare</dc:publisher>
   <dc:source>Articles publicats en revistes (Economia)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>